arrow
M

Max Hardy-Werbin

Hospital del Mar Research Institute
H指数:9
被引数:403

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade

接受免疫检查点阻断的转移性NSCLC患者的分子和免疫学特征与长期获益相关

2025-02-240
OA
Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer
2023-10-202
OAAI
Identifying long-term responders to immune checkpoint blockade: Potential utility of serum proteomic profiling in metastatic non-small cell lung cancer
2023-10-010
OAAI
Evaluation of the host immune response assay SeptiCyte RAPID for potential triage of COVID-19 patients
2023-01-185
OAAI
Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer

血清细胞因子水平可作为小细胞肺癌ipilimumab获益的预测生物标志物

2019-03-2759
OAAI